ruxolitinib,camrelizumab
novartis,incyte,jiangsu hengrui pharmaceuticals
[' cam ', 'ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)', '#mpn', 'mpnsm']
starting monday with #ash22 #mpnsm oral session!
first up up on majic-pv (rux vs bat)
-rux superior for efs
-attainment of cr significant for efs (on either arm)
- &gt;50% jak2 vaf reduction in 56% of rux pts; molec response at 1y assoc with improved outcomes 
Asst Prof & Director Inpatient Leukemia Service @UChicagoMed. @NorthwesternU @Mumedicine @NU_IntMed @UCHemOncFellows alum. tweets=mine. RT?endorsement. He/him